LXRX - Lexicon Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue63,20991,68979,256130,014
Cost of Revenue102,734154,122163,97395,187
Gross Profit-39,525-62,433-84,71734,827
Operating Expenses
Research Development----
Selling General and Administrative63,75466,09043,15723,835
Non Recurring----
Others----
Total Operating Expenses166,488220,212207,130119,022
Operating Income or Loss-103,279-128,523-127,87410,992
Income from Continuing Operations
Total Other Income/Expenses Net-17,269-7,131-3,571-15,674
Earnings Before Interest and Taxes-103,279-128,523-127,87410,992
Interest Expense-20,777-6,984-6,567-6,722
Income Before Tax-120,548-135,654-131,445-4,682
Income Tax Expense--12,661--
Minority Interest----
Net Income From Continuing Ops-120,548-122,993-131,445-4,682
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-120,548-122,993-131,445-4,682
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-120,548-122,993-131,445-4,682